Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 6, Pages 2138-2142Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm058209g
Keywords
-
Categories
Ask authors/readers for more resources
Novel dihydropyrrolopyrazole-substituted benzimidazoles were synthesized and evaluated in vitro as inhibitors of transforming growth factor-beta type I receptor (TGF-beta RI), TGF-beta RII, and mixed lineage kinase-7 (MLK-7). These compounds were found to be potent TGF-beta RI inhibitors and selective versus TGF-beta RII and MLK-7 kinases. Benzimidazole derivative 8b was active in an in vivo target (TGF-beta RI) inhibition assay.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available